FDA guidance 21 CFR Part 11 establishes requirements for the acceptance of electronic records and electronic signatures as legal equivalents to paper records and signatures. It focuses on ensuring that electronic data is authentic, reliable, and equivalent to traditional documents. It covers aspects such as access control, data integrity, and the administration of electronic systems used in the regulatory environment. It is critical for companies operating under FDA regulations and seeking to implement or maintain electronic systems that comply with these standards.